Skip to main content

Blood refuses to go anywhere near this new medical implant material

If you have a medical implant put into your body, you want it to be compatible with blood so as to cause the minimum of possible complications, right? Not necessarily.

A research project coming out of Colorado State University is suggesting a different, less conventional approach: A new type of “superhemophobic” titanium surface that’s so repellent to blood that, in theory, your body won’t even realize an implant is there.

Recommended Videos

“Researchers have been working to try and make implants that blood likes enough to be compatible,” Arun Kota, assistant professor of mechanical engineering and biomedical engineering, told Digital Trends. “We wanted to do the opposite: To make it so that implants are so repellent to blood that blood can’t even contact its surface to make it wet. In a sense, we’re tricking blood into thinking there’s nothing there at all.”

Kota’s lab has worked extensively to develop coatings and surfaces that are repellent to liquids, although this is one of his first dives into this kind of medical implant.

The material developed for this project — in conjunction with Ketul Popat, an associate professor in the same department — starts out as a regular sheet of titanium, the standard material used for medical implants. It is then chemically altered in a way that results in the total rejection of liquids, meaning that there is a barrier between the implant and a person’s blood. That means no clotting and, hopefully, a greatly reduced risk of your body rejecting an implant.

At present, this is still a research project, although Kota said he hopes it will eventually be used in human patients.

“There is still a way to go before it can be commercialized, but we’re excited about the result,” he said. “Right now, we’ve only looked at a couple of parameters, platelet adhesion and activation. The next step is to look at other parameters that influence hemocompatibility. Once we’ve done that, we want to go to in vivo studies in which we intend to implant a superhemophobic surface in a live animal, before we go through an FDA approval process to get these medical implants ready for humans.”

Luke Dormehl
Former Digital Trends Contributor
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Jaguar Land Rover, Nissan hit the brake on shipments to U.S. over tariffs
Range Rover Sport P400e

Jaguar Land Rover (JLR) has announced it will pause shipments of its UK-made cars to the United States this month, while it figures out how to respond to President Donald Trump's 25% tariff on imported cars.

"As we work to address the new trading terms with our business partners, we are taking some short-term actions, including a shipment pause in April, as we develop our mid- to longer-term plans," JLR said in a statement sent to various media.

Read more
DeepSeek readies the next AI disruption with self-improving models
DeepSeek AI chatbot running on an iPhone.

Barely a few months ago, Wall Street’s big bet on generative AI had a moment of reckoning when DeepSeek arrived on the scene. Despite its heavily censored nature, the open source DeepSeek proved that a frontier reasoning AI model doesn’t necessarily require billions of dollars and can be pulled off on modest resources.

It quickly found commercial adoption by giants such as Huawei, Oppo, and Vivo, while the likes of Microsoft, Alibaba, and Tencent quickly gave it a spot on their platforms. Now, the buzzy Chinese company’s next target is self-improving AI models that use a looping judge-reward approach to improve themselves.

Read more
Toyota shifts gears: 15 New EVs and a million cars by 2027
Front three quarter view of the 2023 Toyota bZ4X.

After years of cautiously navigating the electric vehicle (EV) market, Toyota is finally ramping up its commitment to fully electric vehicles.
The Japanese automaker, which has long relied on hybrids, is now planning to develop about 15 fully electric models by 2027, up from five currently. These models will include vehicles under the Toyota and Lexus brands, with production expected to reach 1 million units annually by that year, according to a report from Nikkei.
This strategy marks a significant shift for Toyota, which has thus far remained conservative in its approach to electric cars. The company sold just 140,000 EVs globally in 2024—representing less than 2% of its total global sales. Despite this, Toyota is aiming for a much larger presence in the EV market, targeting approximately 35% of its global production to be electric by the end of the decade.
The Nikkei report suggests the company plans to diversify its production footprint beyond Japan and China and expanding into the U.S., Thailand, and Argentina. This would help mitigate the impact of President Donald Trump’s 25% tariffs on all car imports, as well as reduce delivery times. Toyota is also building a battery plant in North Carolina.
For now, Toyota has only two fully electric vehicles on the U.S. market: The bZ4X  and the Lexus RZ models. The Japanese automaker is expected to introduce new models like the bZ5X and a potential electric version of the popular Tacoma pickup.
Separately, Toyota and Honda, along with South Korea’s Hyundai, all announced on April 4 that they would not be raising prices, at least over the next couple of months, following the imposition of U.S. tariffs. According to a separate Nikkei report, Toyota’s North American division has told its suppliers that it will absorb the extra costs of parts imported from Mexico and Canada. Another 25% for automotive parts imported to the U.S. is slated to come into effect on May 3.

Read more